These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 28102343)
1. Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery. Ng SB; Chua C; Ng M; Gan A; Poon PS; Teo M; Fu C; Leow WQ; Lim KH; Chung A; Koo SL; Choo SP; Ho D; Rozen S; Tan P; Wong M; Burkholder WF; Tan IB Sci Rep; 2017 Jan; 7():40737. PubMed ID: 28102343 [TBL] [Abstract][Full Text] [Related]
2. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay. Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312 [TBL] [Abstract][Full Text] [Related]
3. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival. Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492 [TBL] [Abstract][Full Text] [Related]
4. Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling. Yaegashi M; Iwaya T; Sasaki N; Fujita M; Ju Z; Siwak D; Hachiya T; Sato K; Endo F; Kimura T; Otsuka K; Sugimoto R; Sugai T; Liotta L; Lu Y; Mills GB; Nakagawa H; Nishizuka SS Br J Cancer; 2021 Apr; 124(9):1556-1565. PubMed ID: 33658639 [TBL] [Abstract][Full Text] [Related]
5. Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer. Zhou J; Chang L; Guan Y; Yang L; Xia X; Cui L; Yi X; Lin G PLoS One; 2016; 11(7):e0159708. PubMed ID: 27459628 [TBL] [Abstract][Full Text] [Related]
6. Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer-evaluation in a nationwide Danish cohort. Henriksen TV; Demuth C; Frydendahl A; Nors J; Nesic M; Rasmussen MH; Reinert T; Larsen OH; Jaensch C; Løve US; Andersen PV; Kolbro T; Thorlacius-Ussing O; Monti A; Gögenur M; Kildsig J; Bondeven P; Schlesinger NH; Iversen LH; Gotschalck KA; Andersen CL Ann Oncol; 2024 Feb; 35(2):229-239. PubMed ID: 37992872 [TBL] [Abstract][Full Text] [Related]
7. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation. Mo S; Ye L; Wang D; Han L; Zhou S; Wang H; Dai W; Wang Y; Luo W; Wang R; Xu Y; Cai S; Liu R; Wang Z; Cai G JAMA Oncol; 2023 Jun; 9(6):770-778. PubMed ID: 37079312 [TBL] [Abstract][Full Text] [Related]
13. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer. Ryoo SB; Heo S; Lim Y; Lee W; Cho SH; Ahn J; Kang JK; Kim SY; Kim HP; Bang D; Kang SB; Yu CS; Oh ST; Park JW; Jeong SY; Kim YJ; Park KJ; Han SW; Kim TY Br J Cancer; 2023 Aug; 129(2):374-381. PubMed ID: 37280413 [TBL] [Abstract][Full Text] [Related]
14. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA. Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis. Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803 [TBL] [Abstract][Full Text] [Related]
16. Clinical application of circulating tumour DNA in colorectal cancer. Loft M; To YH; Gibbs P; Tie J Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):837-852. PubMed ID: 37499673 [TBL] [Abstract][Full Text] [Related]
17. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics]. Haupts A; Roth W; Hartmann N Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility of circulating tumor DNA for colorectal cancer. Osumi H; Shinozaki E; Yamaguchi K; Zembutsu H Cancer Sci; 2019 Apr; 110(4):1148-1155. PubMed ID: 30742729 [TBL] [Abstract][Full Text] [Related]
19. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel. Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500 [TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review. Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]